Font Size: a A A
Keyword [Trastuzumab]
Result: 141 - 159 | Page: 8 of 8
141. Research Into Application Of Trastuzumab And Targeted Near-infrared Fluorescent Nanoprobe In Breast Cancer Diagnosis And Treatment
142. The Role Of Radiotherapy For The Postoperative HER2-positive Early Breast Cancer
143. Effects Of Aspirin Combined With Trastuzumab On Proliferation Of Ovarian Cancer SKOV3 Cells
144. Inhibitory Effect Of Icariin Combined With Trastuzumad On Proliferation Of Ovarian Cancer SKOV3 Cells
145. Effect Of Trastuzumab Combined With Nedaplatin On Proliferation Inhibition Of Ovarian Cancer SKOV3 Cells
146. Mechanism Of Combined Inhibitory Effect Of Trastuzumab With Lobaplatin On Ovarian Cancer SKOV-3 Cells
147. Echocardiography In Evaluating The Cardiac Impairment Of Chemotherapy And Targeted Therapy In Breast Cancer Patients
148. Study On Cardiotoxicity Of Trastuzumab In Patients With HER-2 Positive Breast Cancer
149. The Effect Of Trastuzumab On The Survival Of T1 HER-2 Positive Early Breast Cancer Patients
150. Efficacy And Influencing Factors Of Pertuzumab Combined With Trastuzumab In The Neoadjuvant Therapy Of HERT-2 Positive Breast Cancer
151. Efficacy And Safety Of Dual HER2 Blockade Versus A Single-Agent In Trastuzumab-Containing Regimens For HER2-Positive Early Breast Cancer:A Meta-analysis
152. Meta-analysis Of The Efficacy And Safety Of Neoadjuvant Trastuzumab Combined With Pertuzumab For HER2-positive Breast Cancer
153. Observational Study Of Adjuvant And Neoadjuvant Dual-target Therapy For HER2 Positive Breast Cancer
154. Comparisons Of Efficacy And Safety Of Different Second-line Treatments For Trastuzumab-resistant Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
155. The Effect Of ADCC Induced By Trastuzumab In Breast Cancer Cells After Plus Pertuzumab
156. M6A Demethylase FTO Promotes The Resistance Of HER2-positive Breast Cancer Cell To Trastuzumab
157. Study On The Expression Of Related Molecules In The Process Of Drug Resistance And Reversal Of Trastuzumab In HER2 Positive Breast Cancer Cells
158. Study On New Methods Of Structural Characterization And Impurity Analysis Of Three Mab Drugs Including Trastuzumab Base On Mass Spectrometry
159. The Synergistic Effect Of Nrf2 Inhibitor In Combination With Trastuzumab In HER2-positive Tumors And Its Mechanism Of Action
  <<First  <Prev  Next>  Last>>  Jump to